<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The aspect of the <z:chebi fb="46" ids="15035">retinal</z:chebi> vessels may suggest the presence of the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> that can be detected afterwards in the patient's blood by lab tests </plain></SENT>
<SENT sid="1" pm="."><plain>The presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aCL) seems to be the sign for brain ischemic lesions by clotting </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: Three cases of aspects of <z:chebi fb="46" ids="15035">retinal</z:chebi> vessels associated with aCL (<z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>) present in patients with: <z:hpo ids='HP_0003677'>slowly progressive</z:hpo> <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory problems</z:e>, "atypical multiple <z:mp ids='MP_0000612'>sclerosis</z:mp>", <z:hpo ids='HP_0100576'>amaurosis fugax</z:hpo> in contraceptive treatment </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The presence of the aCL antibodies and the aspect of the <z:chebi fb="46" ids="15035">retinal</z:chebi> vessels signaled the possibility of an <z:mp ids='MP_0002551'>abnormal clotting</z:mp> leading to <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Discontinuities in the vessels pathways both in the <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and AFG, suggesting an abnormal blood flow in the <z:chebi fb="46" ids="15035">retinal</z:chebi> vessels, while the aCL present signals a clotting with multiple brain ischemic lesions </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: This aspect of the <z:chebi fb="46" ids="15035">retinal</z:chebi> arterial or/and venous vessels requires laboratory blood dosing for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Their presence will be a definite sign for a future <z:mp ids='MP_0005048'>thrombosis</z:mp> and multiple brain ischemic lesions </plain></SENT>
<SENT sid="7" pm="."><plain>The treatment with sulodexide, initially injectable, then oral formula was used for 6 - 14 months, until the disappearance of the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, but, more than that until the aspect of the <z:chebi fb="46" ids="15035">retinal</z:chebi> vessels went back to <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
</text></document>